Match tier
Listed
Presence
Current · Arkansas
Last published
2022
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
A
Amani Erra
Researcher
Also affiliated: Rush University Medical Center (2022); University of Kentucky (2019); Winthrop Rockefeller Foundation (2021); Saint Joseph Hospital (2019); Presence Saint Joseph Hospital (2017–2019); Hospital Universitario San Rafael (2016)
Faculty Researcher
4 h-index
13 pubs
89 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Amani Erra's research focuses on cancer biology and therapeutics, with a particular interest in squamous cell carcinomas and multiple myeloma. Erra has investigated the presence and potential impact of CrkI-containing microvesicles in squamous cell carcinomas, exploring their ramifications on tumor biology and cancer treatment strategies. In the realm of multiple myeloma, Erra's work has involved assessing the feasibility of outpatient stem cell transplantation and identifying risk factors associated with hospital admission. Additionally, Erra has contributed to the predictive modeling of disease progression in relapsed multiple myeloma, utilizing traditional risk models alongside advanced imaging techniques like PET-CT and minimal residual disease status.
Erra's scholarship metrics include an h-index of 4, with 13 total publications and 88 total citations. Key collaborators at the University of Arkansas for Medical Sciences include Guido Tricot, Sharmilan Thanendrarajan, Sravani Gundarlapalli, and Milan Bimali, with whom Erra has co-authored multiple publications. Erra is actively publishing, with the most recent publication in 2022.
Metrics
- h-index: 4
- Publications: 13
- Citations: 89
Selected Publications
-
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission (2022)
-
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status (2021)
-
Predicting Risk of Progression in Relapsed Multiple Myeloma Using Minimal Residual Disease Status and Focal Lesion Assessment with PET-CT (2020)
-
Feasibility of Outpatient Autologous Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predicting Hospital Admission (2020)
-
A Rare Case of Ipilimumab-induced Reversible Hypophysitis and Permanent Primary Hypothyroidism (2019)
-
PF606 ADVERSE IMPACT OF PRIOR THERAPY ON TRANSPLANT OUTCOME IN MULTIPLE MYELOMA (2019)
-
Appropriateness of Heparin-Induced Thrombocytopenia (HIT) Testing and the Reliability of 4-Ts Scoring in Critically Ill Patients (2018)
Collaboration Network
Top Collaborators
Mathew Kottarathara
University of Arkansas for Medical Sciences (US)
2 shared publications
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Richa Parikh
University of Arkansas for Medical Sciences (US)
2 shared publications
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Angel Mitma
University of Arkansas for Medical Sciences (US)
2 shared publications
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Pankaj Mathur
University of Arkansas for Medical Sciences (US)
2 shared publications
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Yetunde Ogunsesan
University of Arkansas for Medical Sciences (US)
2 shared publications
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Lakshmi Yarlagadda
University of Arkansas for Medical Sciences (US)
2 shared publications
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Sravani Gundarlapalli
University of Arkansas for Medical Sciences
2 shared publications
In database
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
2 shared publications
In database
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Maurizio Zangari
University of Arkansas for Medical Sciences
2 shared publications
In database
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Frits van Rhee
University of Arkansas for Medical Sciences
2 shared publications
In database
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Guido Tricot
University of Arkansas for Medical Sciences
2 shared publications
In database
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Carolina Schinke
University of Arkansas for Medical Sciences
2 shared publications
In database
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
David L. Baker
Winthrop Rockefeller Foundation (US)
1 shared publication
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Milan Bimali
Arkansas Children's Hospital
1 shared publication
In database
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Luis F. Carrillo
University of Arkansas for Medical Sciences (US)
1 shared publication
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Similar Researchers
Based on overlapping research topics
Clyde Bailey
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Monica Graziutti
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Asis Shrestha
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Naveen Yarlagadda
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Behjatolah Monzavi Karbassi
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Fumou Sun
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology